Treatment of benign eyelid lesions with Nd:YVO laser: a prospective study

J Cosmet Laser Ther. 2020 Apr 2;22(3):146-149. doi: 10.1080/14764172.2020.1767787. Epub 2020 Jun 4.


The purpose of this prospective cohort study, including consecutively selected patients, was to evaluate the outcomes of Nd:YVO laser-assisted photocoagulation for the removal of benign eyelid lesions. An emulsion of lidocaine and prilocaine was used for dermal analgesia and subcutaneous injection of 2% lidocaine was performed as needed. Follow-up included two visits, at day 15 and 45 postoperatively, in order to assess time of wound healing, postoperative complications, need for additional treatment, and patient's satisfaction. A total of 101 lesions of 66 patients were included, with a mean age of 55.4 ± 15.3 years. All patients were Caucasian and 62% were female. Papilloma was the most common lesion identified (61%). No major complications were reported during and after the procedure. Complete epithelization occurred in 82% and 100%, at the 15 and 45-day visit, respectively. All patients were satisfied with the cosmetic result. Only one patient was proposed for additional therapy during the follow-up period. In conclusion, this study supports Nd:YVO laser-assisted treatment as an effective and safe alternative to conventional surgery for the removal of benign eyelid lesions. The technique is well accepted, easy to perform, and provides excellent cosmetic and functional results.

Keywords: Nd:YVO laser; benign lesion; eyelid; prospective.

MeSH terms

  • Adult
  • Aged
  • Eyelids / surgery*
  • Female
  • Humans
  • Laser Coagulation*
  • Laser Therapy*
  • Lasers
  • Male
  • Middle Aged
  • Prospective Studies
  • Wound Healing